Literature DB >> 23461621

Synthesis of biotinylated episilvestrol: highly selective targeting of the translation factors eIF4AI/II.

Jennifer M Chambers1, Lisa M Lindqvist, Andrew Webb, David C S Huang, G Paul Savage, Mark A Rizzacasa.   

Abstract

Silvestrol (1) and episilvestrol (2) are protein synthesis inhibitors, and the former has shown efficacy in multiple mouse models of cancer; however, the selectivity of these potent cytotoxic natural products has not been described. Herein, it is demonstrated that eukaryotic initiation factors eIF4AI/II were the only proteins detected to bind silvestrol (1) and biotinylated episilvestrol (9) by affinity purification. Our study demonstrates the remarkable selectivity of these promising chemotherapeutics.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23461621     DOI: 10.1021/ol400401d

Source DB:  PubMed          Journal:  Org Lett        ISSN: 1523-7052            Impact factor:   6.005


  20 in total

Review 1.  Stress granules, P-bodies and cancer.

Authors:  Paul Anderson; Nancy Kedersha; Pavel Ivanov
Journal:  Biochim Biophys Acta       Date:  2014-12-05

2.  Target-Based Screening against eIF4A1 Reveals the Marine Natural Product Elatol as a Novel Inhibitor of Translation Initiation with In Vivo Antitumor Activity.

Authors:  Tara L Peters; Joseph Tillotson; Alison M Yeomans; Sarah Wilmore; Elizabeth Lemm; Carlos Jiménez-Romero; Luis A Amador; Lingxiao Li; Amit D Amin; Praechompoo Pongtornpipat; Christopher J Zerio; Andrew J Ambrose; Gillian Paine-Murrieta; Patricia Greninger; Francisco Vega; Cyril H Benes; Graham Packham; Abimael D Rodríguez; Eli Chapman; Jonathan H Schatz
Journal:  Clin Cancer Res       Date:  2018-05-29       Impact factor: 12.531

Review 3.  Rocaglamide, silvestrol and structurally related bioactive compounds from Aglaia species.

Authors:  Li Pan; John L Woodard; David M Lucas; James R Fuchs; A Douglas Kinghorn
Journal:  Nat Prod Rep       Date:  2014-05-02       Impact factor: 13.423

Review 4.  Therapeutic Opportunities in Eukaryotic Translation.

Authors:  Jennifer Chu; Jerry Pelletier
Journal:  Cold Spring Harb Perspect Biol       Date:  2018-06-01       Impact factor: 10.005

Review 5.  Discovery of Anticancer Agents of Diverse Natural Origin.

Authors:  A Douglas Kinghorn; Esperanza J Carcache DE Blanco; David M Lucas; H Liva Rakotondraibe; Jimmy Orjala; D Doel Soejarto; Nicholas H Oberlies; Cedric J Pearce; Mansukh C Wani; Brent R Stockwell; Joanna E Burdette; Steven M Swanson; James R Fuchs; Mitchell A Phelps; Lihui Xu; Xiaoli Zhang; Young Yongchun Shen
Journal:  Anticancer Res       Date:  2016-11       Impact factor: 2.480

6.  Components of the eIF4F complex are potential therapeutic targets for malignant peripheral nerve sheath tumors and vestibular schwannomas.

Authors:  Janet L Oblinger; Sarah S Burns; Elena M Akhmametyeva; Jie Huang; Li Pan; Yulin Ren; Rulong Shen; Beth Miles-Markley; Aaron C Moberly; A Douglas Kinghorn; D Bradley Welling; Long-Sheng Chang
Journal:  Neuro Oncol       Date:  2016-03-06       Impact factor: 12.300

7.  Evidence for a functionally relevant rocaglamide binding site on the eIF4A-RNA complex.

Authors:  Heather Sadlish; Gabriela Galicia-Vazquez; C Gregory Paris; Thomas Aust; Bhupinder Bhullar; Lena Chang; Stephen B Helliwell; Dominic Hoepfner; Britta Knapp; Ralph Riedl; Silvio Roggo; Sven Schuierer; Christian Studer; John A Porco; Jerry Pelletier; N Rao Movva
Journal:  ACS Chem Biol       Date:  2013-05-07       Impact factor: 5.100

8.  Flavaglines target primitive leukemia cells and enhance anti-leukemia drug activity.

Authors:  K P Callahan; M Minhajuddin; C Corbett; E D Lagadinou; R M Rossi; V Grose; M M Balys; L Pan; S Jacob; A Frontier; M R Grever; D M Lucas; A D Kinghorn; J L Liesveld; M W Becker; C T Jordan
Journal:  Leukemia       Date:  2014-02-28       Impact factor: 11.528

9.  Cyclopenta[b]benzofuran and Secodammarane Derivatives from the Stems of Aglaia stellatopilosa.

Authors:  Nuraqilah Othman; Li Pan; Michele Mejin; Julian C L Voong; Hee-byung Chai; Caroline M Pannell; A Douglas Kinghorn; Tiong C Yeo
Journal:  J Nat Prod       Date:  2016-03-14       Impact factor: 4.050

10.  Artificial Iron Proteins: Modeling the Active Sites in Non-Heme Dioxygenases.

Authors:  Kelsey R Miller; Jonathan D Paretsky; Alec H Follmer; Tillmann Heinisch; Kaustuv Mittra; Sheraz Gul; In-Sik Kim; Franklin D Fuller; Alexander Batyuk; Kyle D Sutherlin; Aaron S Brewster; Asmit Bhowmick; Nicholas K Sauter; Jan Kern; Junko Yano; Michael T Green; Thomas R Ward; A S Borovik
Journal:  Inorg Chem       Date:  2020-04-20       Impact factor: 5.165

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.